These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33439758)

  • 1. Contrast-enhanced ultrasound in evaluation of adrenal lesions with CT/MRI correlation.
    Aggarwal A; Das CJ
    Br J Radiol; 2021 Apr; 94(1120):20201170. PubMed ID: 33439758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation between benign and malignant adrenal mass using contrast-enhanced ultrasound.
    Friedrich-Rust M; Glasemann T; Polta A; Eichler K; Holzer K; Kriener S; Herrmann E; Nierhoff J; Bon D; Bechstein WO; Vogl T; Zeuzem S; Bojunga J
    Ultraschall Med; 2011 Oct; 32(5):460-71. PubMed ID: 21667434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced ultrasound for imaging of adrenal masses.
    Dietrich CF; Ignee A; Barreiros AP; Schreiber-Dietrich D; Sienz M; Bojunga J; Braden B
    Ultraschall Med; 2010 Apr; 31(2):163-8. PubMed ID: 19401979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced sonography of adrenal masses: differentiation of adenomas and nonadenomatous lesions.
    Friedrich-Rust M; Schneider G; Bohle RM; Herrmann E; Sarrazin C; Zeuzem S; Bojunga J
    AJR Am J Roentgenol; 2008 Dec; 191(6):1852-60. PubMed ID: 19020259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Sonazoid contrast-enhanced ultrasound to contrast-enhanced CT and MRI for differentially diagnosing renal lesions: a prospective multicenter study.
    Zhao QX; Wu C; Tan S; Yang Y; Cui XW; Dietrich CF; Yang B; Xu CL; Gao YY; Xie MX; Wu CJ; Liu LP; Wang XH; Ling-Hu RZ; Wang N; Wang F; Wang XL; Liu GY; Yu XL; Yu J; Cheng ZG; Liang P
    World J Urol; 2024 May; 42(1):302. PubMed ID: 38720010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional value of contrast-enhanced ultrasound (CEUS) on arterial phase non-hyperenhancement observations (≥ 2 cm) of CT/MRI for high-risk patients: focusing on the CT/MRI LI-RADS categories LR-3 and LR-4.
    Kang HJ; Kim JH; Joo I; Han JK
    Abdom Radiol (NY); 2020 Jan; 45(1):55-63. PubMed ID: 31332503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of parametric ultrasound contrast agent perfusion studies for differentiation of hyperplastic adrenal nodules from adenomas-Initial study.
    Slapa RZ; Kasperlik-Zaluska AA; Migda B; Otto M; Jakubowski WS
    Eur J Radiol; 2015 Aug; 84(8):1432-1435. PubMed ID: 26032129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of incidentally discovered adrenal masses with PET and PET/CT.
    Wong KK; Arabi M; Bou-Assaly W; Marzola MC; Rubello D; Gross MD
    Eur J Radiol; 2012 Mar; 81(3):441-50. PubMed ID: 21295930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical-shift MRI versus washout CT for characterizing adrenal incidentalomas.
    Warda MH; Shehata SM; Zaiton F
    Clin Imaging; 2016; 40(4):780-7. PubMed ID: 27317224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal imaging for adenoma characterization: imaging features, diagnostic accuracies and differential diagnoses.
    Park JJ; Park BK; Kim CK
    Br J Radiol; 2016 Jun; 89(1062):20151018. PubMed ID: 26867466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases.
    Sawatzki M; Güller U; Güsewell S; Husarik DB; Semela D; Brand S
    J Hepatol; 2021 Feb; 74(2):419-427. PubMed ID: 33065168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal masses: contemporary imaging characterization.
    Malayeri AA; Zaheer A; Fishman EK; Macura KJ
    J Comput Assist Tomogr; 2013; 37(4):528-42. PubMed ID: 23863528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Indeterminate Liver Lesions on CT and MRI With Contrast-Enhanced Ultrasound: What Is the Evidence?
    Wang DC; Jang HJ; Kim TK
    AJR Am J Roentgenol; 2020 Jun; 214(6):1295-1304. PubMed ID: 32182094
    [No Abstract]   [Full Text] [Related]  

  • 15. Morphologic features of 211 adrenal masses at initial contrast-enhanced CT: can we differentiate benign from malignant lesions using imaging features alone?
    Song JH; Grand DJ; Beland MD; Chang KJ; Machan JT; Mayo-Smith WW
    AJR Am J Roentgenol; 2013 Dec; 201(6):1248-53. PubMed ID: 24261363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective Analysis of Contrast-enhanced Ultrasonography Effectiveness in Reducing Time to Diagnosis and Imaging-related Expenditures at a Single Large United States County Hospital.
    Streb JW; Tchelepi H; Malhi H; Deurdulian C; Grant EG
    Ultrasound Q; 2019 Jun; 35(2):99-102. PubMed ID: 30169489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The indeterminate adrenal lesion.
    Sahdev A; Willatt J; Francis IR; Reznek RH
    Cancer Imaging; 2010 Mar; 10(1):102-13. PubMed ID: 20299300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional value of contrast-enhanced ultrasonography for fusion-guided, percutaneous biopsies of focal liver lesions: prospective feasibility study.
    Kang HJ; Kim JH; Lee SM; Yang HK; Ahn SJ; Han JK
    Abdom Radiol (NY); 2018 Dec; 43(12):3279-3287. PubMed ID: 29671007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bosniak classification system: a prospective comparison of CT, contrast-enhanced US, and MR for categorizing complex renal cystic masses.
    Graumann O; Osther SS; Karstoft J; Hørlyck A; Osther PJ
    Acta Radiol; 2016 Nov; 57(11):1409-1417. PubMed ID: 26019242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
    Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.